Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,660,016
  • Shares Outstanding, K 133,732
  • Annual Sales, $ 7,726 M
  • Annual Income, $ 858,000 K
  • 60-Month Beta 1.39
  • Price/Sales 2.07
  • Price/Cash Flow 13.14
  • Price/Book 2.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.13
  • Number of Estimates 8
  • High Estimate 0.50
  • Low Estimate -0.66
  • Prior Year 1.73
  • Growth Rate Est. (year over year) -92.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.78 +11.76%
on 05/14/20
123.87 -5.47%
on 06/03/20
+8.79 (+8.12%)
since 05/05/20
3-Month
73.02 +60.37%
on 04/03/20
125.00 -6.32%
on 04/28/20
+1.42 (+1.23%)
since 03/05/20
52-Week
73.02 +60.37%
on 04/03/20
125.00 -6.32%
on 04/28/20
+19.35 (+19.80%)
since 06/05/19

Most Recent Stories

More News
Quest Diagnostic Has Returned % Since SmarTrend Recommendation (DGX)

SmarTrend identified a Downtrend for Quest Diagnostic (NYSE:DGX) on April 8th, 2020 at $86.50. In approximately 2 months, Quest Diagnostic has returned 40.06% as of today's recent price of $121.15.

DGX : 117.10 (-2.03%)
DGX vs. EHC: Which Stock Should Value Investors Buy Now?

DGX vs. EHC: Which Stock Is the Better Value Option?

DGX : 117.10 (-2.03%)
EHC : 73.24 (+2.30%)
Quest Diagnostics' Self-Collection Coronavirus Kit Gets EUA

This kit by Quest Diagnostics (DGX) is suitable for use in children supervised by an adult.

DGX : 117.10 (-2.03%)
OMI : 7.89 (+1.15%)
SRDX : 42.24 (+4.22%)
APHA : 4.39 (-1.13%)
Quest Diagnostics to Speak at the Jefferies Virtual Healthcare Conference

, /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare...

DGX : 117.10 (-2.03%)
Home State Health and Quest Diagnostics Team Up to Increase Access to COVID-19 Testing in Underserved Communities

, /PRNewswire/ -- Home State Health announced a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse...

DGX : 117.10 (-2.03%)
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use

, /PRNewswire/ --  (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration...

DGX : 117.10 (-2.03%)
Non-Invasive Prenatal Testing (NIPT) Market Assessment 2015-2025: Implications of the COVID-19 Crisis

, /PRNewswire/ -- The report has been added to offering.

ERRFY : 16.7500 (+7.72%)
MYGN : 16.48 (+3.52%)
DGX : 117.10 (-2.03%)
Quest Diagnostics Launches COVID-19 Workforce Testing Services to Help Guide Organizations in Fostering Safer Workplaces as Employees Return to Work

, /PRNewswire/ --  (NYSE: DGX), the world's leading provider of diagnostic information services, today launched a new suite of Return to Work services built around large-scale workforce COVID-19 testing....

DGX : 117.10 (-2.03%)
MeMD Enables Consumers, Businesses to Order COVID-19 Antibody Testing

As governments and businesses evaluate "return to work" strategies amid the COVID-19 pandemic, national telehealth provider MeMD aims to make antibody testing readily available to Americans through its...

DGX : 117.10 (-2.03%)
LH : 179.74 (-0.50%)
Why Is Quest Diagnostics (DGX) Up 12.3% Since Last Earnings Report?

Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DGX : 117.10 (-2.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade DGX with:

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Key Turning Points

2nd Resistance Point 122.11
1st Resistance Point 119.61
Last Price 117.10
1st Support Level 115.63
2nd Support Level 114.16

See More

52-Week High 125.00
Last Price 117.10
Fibonacci 61.8% 105.14
Fibonacci 50% 99.01
Fibonacci 38.2% 92.88
52-Week Low 73.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar